Hoping Someday Never Comes: Deferring Ethical Thinking About Noninvasive Prenatal Testing

AJOB Empirical Bioethics

Volumn 6, Issue 1, 2015, Pages 31-41

  Mozersky, Jessica ^a  

^a NEW SCHOOL FOR SOCIAL RESEARCH   (United States)

Author keywords

bioethics; commercialization; deferral; ethnography; NIPT; reassurance

Indexed keywords

EID: 84924350166     PISSN: 23294515     EISSN: 23294523     Source Type: Journal    
DOI: 10.1080/23294515.2014.993097     Document Type: Article

References (47)

1. Adzick, N. S., E. A. Thom, C.Y. Spong, 2011. A randomized trial of prenatal versus postnatal repair of myelomeningocele. New England Journal of Medicine 364(11): 993–1004. http://dx.doi.org/10.1056/NEJMoa1014379
2. Ahman, A., K. Runestam, and A. Sarkadi. 2010. Did I really want to know this? Pregnant women's reaction to detection of a soft marker during ultrasound screening. Patient Education and Counseling 81(1): 87–93. http://dx.doi.org/10.1016/j.pec.2009.12.011
3. Allyse M. A., L. C. Sayres, J. S. King, M. E. Norton, and M. K. Cho. 2012. Cell-free fetal DNA testing for fetal aneuploidy and beyond: Clinical integration challenges in the US context. Human Reproduction 27(11): 3123–31. http://dx.doi.org/10.1093/humrep/des286
4. Agarwal, A., L. C. Sayres, M. K. Cho, R. Cook-Deegan, and S. Chandrasekharan. 2013. Commercial landscape of noninvasive prenatal testing in the United States. Prenatal Diagnosis 33(6): 521–31. http://dx.doi.org/10.1002/pd.4101
5. Benn, P. A., and A. R. Chapman. 2010. Ethical challenges in providing noninvasive prenatal diagnosis. Current Opinion in Obstetrics and Gynecology 22(2): 128–34.
6. Bernhardt, B., A. G. Geller, T. Doksum, S. M. Larson, D. Roter, and N. A. Holtzman. 1998. Prenatal genetic testing: content of discussions between obstetric providers and pregnant women. Obstetrics & Gynecology 91(5 pt 1): 648–55. http://dx.doi.org/10.1016/S0029-7844(98)00011-8
7. Bernhardt, B. A., C. Mastromarino Haunstetter, D. Roter, and G. Geller. 2005. How do obstetric providers discuss referrals for prenatal genetic counseling? Journal of Genetic Counseling 14(2): 109–17. http://dx.doi.org/10.1007/s10897-005-4064-0
8. Bernhardt, B. A., D. Soucier, K. Hanson, M. S. Savage, L. Jackson, and R. J. Wapner. 2013. Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genetics in Medicine 15(2): 139–45. http://dx.doi.org/10.1038/gim.2012.113
9. Bianchi, D. W. 2012. From prenatal genomic diagnosis to fetal personalized medicine: Progress and challenges. Nature Medicine 18(7): 1041–51. http://dx.doi.org/10.1038/nm.2829
10. Bianchi, D. W., R. L. Parker, J. Wentworth, 2014. DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine 370(9): 799–808. http://dx.doi.org/10.1056/NEJMoa1311037
11. Bosk, C. L. 1999. Professional ethicist available: Logical, secular, friendly. Daedalus 128(4): 47–68.
12. Check Hayden, E. 2012. Fetal tests spur legal battle. Nature 486(7404): 454. http://dx.doi.org/10.1038/486454a
13. Churchill, L. R., and D. Schenck. 2005. One cheer for bioethics: Engaging the moral experiences of patients and practitioners beyond the big decisions. Cambridge Quarterly of Healthcare Ethics 14(4): 389–403. http://dx.doi.org/10.1017/S0963180105050541
14. De Jong, A., W. J. Dondorp, S. G. M. Frints, C. E. M. de Die-Smulders, and G. M. W. R. de Wert. 2011. Advances in prenatal screening: the ethical dimension. Nature Reviews Genetics 12(9): 657–63. http://dx.doi.org/10.1038/nrg3036
15. Deans, Z., and A.J. Newson. 2010. Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Analysis 19 (March): 122–32. http://dx.doi.org/10.1007/s10728-010-0146-8
16. Faden, R. R., A. J. Chwalow, E. Orel-Crosby, N. A. Holtzman, G.A. Chase, and C.O. Leonard. 1985. What participants understand about a maternal serum alpha-fetoprotein screening program. American Journal of Public Health 75(12): 1381–4. http://dx.doi.org/10.2105/AJPH.75.12.1381
17. Fan, H. C., W. Gu, J. Wang, Y. J. Blumenfeld, Y. Y. El-Sayed, and S. R. Quake. 2012. Non-invasive prenatal measurement of the fetal genome. Nature 487(7407): 320–4. http://dx.doi.org/10.1038/nature11251
18. Farrelly, E., M. K. Cho, L. Erby, D. Roter, A. Stenzel, and K. Ormond. 2012. Genetic counseling for prenatal testing: where is the discussion about disability? Journal of Genetic Counseling 21(6): 814–24. http://dx.doi.org/10.1007/s10897-012-9484-z
19. Fox, R. C., and J. P. Swazey. 2005. Examining American bioethics: its problems and prospects. Cambridge Quarterly of Healthcare Ethics 14(4): 361–73. http://dx.doi.org/10.1017/S0963180105050504
20. Garel, M., S. Gosme-Seguret, M. Kaminski, and M. Cuttinin. 2002. Ethical decision-making in prenatal diagnosis: A qualitative survey among physicians and midwives. Prenatal Diagnosis 22(9): 811–7. http://dx.doi.org/10.1002/pd.427
21. Greely, H. T. 2011. Get ready for the flood of fetal gene screening. Nature 469(7330): 289–91. http://dx.doi.org/10.1038/469289a
22. Hunt, L. M., K. B. de Voogd, and H. Castañeda. 2005. The routine and the traumatic in prenatal genetic diagnosis: Does clinical information inform patient decision-making? Patient Education and Counseling 56(3): 302–12. http://dx.doi.org/10.1016/j.pec.2004.03.004
23. Kaufman, S. 2001. Clinical narratives and ethical dilemmas. In Bioethics in social context, ed. B. Hoffmaster, 12–38. Philadelphia, PA: Temple University Press.
24. Kleinman, A. 1997. Writing at the margin: Discourse between anthropology and medicine. Berkeley, CA: University of California Press.
25. Kleinman, A. 1999. Moral experience and ethical reflection: Can ethnography reconcile them? A quandary for “the new bioethics.” Daedalus 128(4): 69–97.
26. McGoey, L. 2007. On the will to ignorance in bureaucracy. Economy and Society 36(2): 212–35. http://dx.doi.org/10.1080/03085140701254282
27. McGoey, L. 2012. The logic of strategic ignorance. British Journal of Sociology 63(3): 533–76. http://dx.doi.org/10.1111/j.1468-4446.2012.01424.x
28. Mennuti, M. T., A. M. Cherry, J. D. Morrissette, and L. Dugoff. 2013. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? American Journal of Obstetrics and Gynecology 209(5): 415–9. http://dx.doi.org/10.1016/j.ajog.2013.03.027
29. Morain, S., M. F. Greene, and M. M. Mello. 2013. A new era in noninvasive prenatal testing. New England Journal of Medicine 369(6): 499–501. http://dx.doi.org/10.1056/NEJMp1304843
30. Mozersky, J., and M. T. Mennuti. 2013. Cell-free fetal DNA testing: who is driving implementation? Genetics in Medicine 15(6): 433–4. http://dx.doi.org/10.1038/gim.2012.156
31. Natoli, J. L., D. L. Ackerman, S. McDermott, and J. G. Edwards. 2012. Prenatal diagnosis of Down syndrome: A systematic review of termination rates (1995–2011). Prenatal Diagnosis 32(2): 142–53. http://dx.doi.org/10.1002/pd.2910
32. Newson, A. J. 2008. Ethical aspects arising from non-invasive fetal diagnosis. Seminars in Fetal and Neonatal Medicine 13(2): 103–8. http://dx.doi.org/10.1016/j.siny.2007.12.004
33. Norton M. E., N. C. Rose, and P. Benn. 2013. Noninvasive prenatal testing for fetal aneuploidy: Clinical assessment and a plea for restraint. Obstetrics & Gynecology 121(4): 847–50. http://dx.doi.org/10.1097/AOG.0b013e31828642c6
34. Palomaki, G. E., E. M. Kloza, G.M. Lambert-Messerlian, 2011. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genetics in Medicine 13(11): 913–020. http://dx.doi.org/10.1097/GIM.0b013e3182368a0e
35. Press, N. 2008. Genetic testing and screening. In From birth to death and bench to clinic: The Hastings Center bioethics briefing book for journalists, policymakers, and campaigns, ed. M. Crowley, 73–78. Garrison, NY: Hastings Center.
36. Press, N. A., and C. H. Browner. 1994. Collective silences, collective fictions: How prenatal diagnostic testing became part of routine prenatal care. In Women and prenatal testing: Facing the challenges of genetic technology, ed. K. H. Rothenberg and E. J. Thomson, 201–18. Columbus, OH: Ohio State University Press.
37. Press, N. A., and C. H. Browner. 1995. Risk, autonomy, and responsibility: Informed consent for prenatal testing. Hastings Center Report 25(3): S9.
38. Press, N. A., and C. H. Browner. 1997. Why women say yes to prenatal diagnosis. Social Science & Medicine 45(7): 979–89. http://dx.doi.org/10.1016/S0277-9536(97)00011-7
39. Rapp, R. 2000. Testing women, testing the fetus: The social impact of amniocentesis in America. New York, NY: Routledge.
40. Rapp, R., and F. D. Ginsburg. 2001. Enabling disability: Rewriting kinship, reimagining citizenship. Public Culture 13(3): 533–56. http://dx.doi.org/10.1215/08992363-13-3-533
41. Resta, R. G. 1997. Eugenics and nondirectiveness in genetic counseling. Journal of Genetic Counseling 6(2): 255–8. http://dx.doi.org/10.1023/A:1025624505382
42. Resta, R. G. 1998. Eugenic considerations in the theory and practice of genetic counseling. Science in Context 11(3–4): 431–8. http://dx.doi.org/10.1017/S0269889700003124
43. Rothman, B. K. 1987. The tentative pregnancy: Prenatal diagnosis and the future of motherhood. New York, NY: W. W. Norton.
44. Seale, C. 2004. Researching society and culture (2nd ed.). London, UK: Sage.
45. Stern, A. M. 2012. Telling genes: The story of genetic counseling in America. Baltimore, MD: Johns Hopkins University Press
46. Van den Heuvel, A., L. Chitty, E. Dormandy, 2010. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Education and Counseling 78(1): 24–28. http://dx.doi.org/10.1016/j.pec.2009.05.014
47. Wang, J. C., T. Sahoo, S. Schonberg, 2014. Discordant noninvasive prenatal testing and cytogenetic results: A study of 109 consecutive cases. Genetics in Medicine August 7 (Epub ahead of print). http://dx.doi.org/10.1038/gim.2014.92